Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471805 · ClinicalTrials.gov registry record · NA
4 mA tDCS, Estrogen, and Leg Muscle Fatigability
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04471805 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 10 participants.
The verdict
NCT04471805, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The majority of transcranial direct current stimulation (tDCS) studies have failed to consider sex as a modulating factor. This neglect may partly account for the high inter-subject variability bemoaned by many tDCS investigators (e.g., approximately 50% of participants do not respond to tDCS) and has certainly delayed progress in the field. Therefore, research into how sex influences stimulation-related outcomes is vital to fully understand the underlying mechanisms of tDCS, which has shown great inconsistency. Because of the menstrual cycle, the hormonal levels of women fluctuate considerably more than in men. Importantly, these hormonal variations might impact the efficacy of neuromodulatory tools, like tDCS. It is suggested that estrogen, which is high in the second follicular phase, reinforces excitatory mechanisms in the motor cortex. However, because anodal tDCS enhances cortical excitation there is also a possibility of excessive excitability. For instance, anodal tDCS may lead to overexcitation and non-optimal performance when it is applied in the second follicular phase of the menstrual cycle. Currently, there is a lack of knowledge on how the phases of the menstrual cycle affect tDCS performance outcomes in healthy young women because no studies have examined if and how the phases of the menstrual cycle alter tDCS efficacy. This study is critical for determining the optimal time to administer anodal tDCS, and the ideal intensity for that administration, to achieve the most beneficial results. Furthermore, this investigation will emphasize the need for future tDCS studies to test women during the same menstrual cycle phase.
Interventions
- DEVICE Sham transcranial direct current stimulation 4 mA
- DEVICE Transcranial direct current stimulation 4 mA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471805
The ClinicalTrials.gov registry entry for NCT04471805 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham transcranial direct current stimulation 4 mA is the first listed.
NCT04471805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04471805 about?
NCT04471805 is a clinical study titled "4 mA tDCS, Estrogen, and Leg Muscle Fatigability". The majority of transcranial direct current stimulation (tDCS) studies have failed to consider sex as a modulating factor. This neglect may partly account for the high inter-subject variability bemoaned by many tDCS investigators (e.g., approximately 50% of participants do not respond to tDCS) and h...
What is the current status of trial NCT04471805?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-10-01. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04471805?
The interventions under investigation include: Sham transcranial direct current stimulation 4 mA (DEVICE), Transcranial direct current stimulation 4 mA (DEVICE).
Who is sponsoring clinical trial NCT04471805?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.